Detalhe da pesquisa
1.
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
Harm Reduct J
; 20(1): 51, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060027
2.
The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: Autonomy, advocacy and action.
J Subst Use Addict Treat
; 154: 209154, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652211
3.
Changes in daily dose in open-label compared to double-blind: The role of clients' expectations in injectable opioid agonist treatment.
Addict Behav Rep
; 17: 100490, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37124402
4.
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
Int J Drug Policy
; 117: 104058, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182352
5.
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review.
Subst Abuse Treat Prev Policy
; 18(1): 56, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777766